BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

  May 8, 2025

   · 

  2 min read
• Press Releases

  RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%

  May 8, 2025

   · 

  19 min read
• Press Releases

  Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T Cell Agonist, Invikafusp Alfa in Combination with TROP2-directed ADC Trodelvy® in Metastatic Breast Cancer

  May 8, 2025

   · 

  4 min read
• Press Releases

  World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer

  May 8, 2025

   · 

  4 min read
• Press Releases

  Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

  May 8, 2025

   · 

  12 min read
• Press Releases

  Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo

  May 8, 2025

   · 

  10 min read
• Press Releases

  HLS Therapeutics Announces Q1 2025 Financial Results

  May 8, 2025

   · 

  16 min read
• Press Releases

  Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

  May 8, 2025

   · 

  10 min read
• Press Releases

  ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025

  May 8, 2025

   · 

  6 min read
• Press Releases

  Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

  May 8, 2025

   · 

  41 min read